Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) shares gapped down prior to trading on Wednesday . The stock had previously closed at $16.65, but opened at $16.13. Sysmex shares last traded at $16.80, with a volume of 749 shares trading hands.
Sysmex Stock Up 1.0%
The stock has a market cap of $10.58 billion, a price-to-earnings ratio of 30.03 and a beta of 1.14. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.30 and a current ratio of 2.97. The firm's 50-day simple moving average is $17.15 and its two-hundred day simple moving average is $18.07.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last issued its earnings results on Wednesday, May 14th. The company reported $0.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.04). The business had revenue of $958.89 million during the quarter, compared to the consensus estimate of $991.22 million. Sysmex had a net margin of 10.56% and a return on equity of 11.81%. On average, sell-side analysts expect that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.
Sysmex Company Profile
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
See Also
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
